【序号】:1 【作者】:Aayam Lamichhane 【题名】:The mucosal immune system for vaccinedevelopment 【期刊】:Vaccine 【年、卷、期、起止页码】:Volume 32, Issue 49, 20November 2014, Pages 6711–6723 【全文链接】:http://www.sciencedirect.com/science/article/pii/S0264410X1401370X
【序号】:2 【作者】:Jan T Poolman, Carla CAM Peeters, and GermiePJM van den Dobbelsteen 【题名】:The history of pneumococcal conjugate vaccinedevelopment: dose selection 【期刊】:Expert Review of Vaccines 【年、卷、期、起止页码】:December 2013, Vol. 12,No. 12 , Pages 1379-1394 【全文链接】:http://informahealthcare.com/doi/abs/10.1586/14760584.2013.852475
【序号】:3 【作者】:Ruth Mitchell, Johannes Trück, and Andrew JPollard 【题名】:Use of the 13-valent pneumococcal conjugatevaccine in children and adolescents aged 6 – 17 years 【期刊】:Expert Opinion on Biological Therapy 【年、卷、期、起止页码】:October 2013, Vol. 13,No. 10 , Pages 1451-1465 【全文链接】:http://informahealthcare.com/doi/abs/10.1517/14712598.2013.824419
【序号】:4 【作者】:Simon Athlin 【题名】:Association between Serotype-Specific AntibodyResponse and Serotype Characteristics in Patients with Pneumococcal Pneumonia,with Special Reference to Degree of Encapsulation and Invasive Potential 【期刊】:Clinical and Vaccine Immunology 【年、卷、期、起止页码】:November 2014 vol. 21no. 11 1541-1549 【全文链接】:http://cvi.asm.org/content/21/11/1541.abstract
【序号】:5 【作者】:William P Hausdorff, Bernard Hoet, Richard AAdegbola 【题名】:Predicting the impact of new pneumococcalconjugate vaccines: serotype composition is not enough 【期刊】:Expert Review of Vaccines